Muscle biopsy superficial

CPT code 20200 covers a superficial muscle biopsy, where a physician removes a small sample of muscle tissue near the skin's surface for laboratory testing to diagnose muscle diseases, infections, or other conditions.

Showing rates for

National Average

Base Medicare rate

$207.66

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

1.46

PE RVU (NF)

4.58

MP RVU

0.38

Total RVU

6.42

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Verify place of service code carefully - bill POS 22 (on-campus outpatient hospital) or 11 (office) to receive non-facility rate of $207.66 versus facility rate of $93.80
Impact: Correct POS coding ensures maximum reimbursement difference of $113.86 per procedure
Document specific muscle(s) biopsied with anatomic detail (e.g., left deltoid, right vastus lateralis) as vague documentation invites denials and downcoding
Impact: Prevents 15-25% denial rate for insufficient anatomic specificity
Do not bill 20200 with deep muscle biopsy codes (20205, 20206) for the same anatomic area as these are mutually exclusive
Impact: Avoids automatic denial and potential $93.80-$207.66 payment recoupment
Link appropriate ICD-10 codes demonstrating medical necessity such as M60.9 (myositis), M62.81 (muscle weakness), G72.9 (myopathy), or R79.89 (elevated CK)
Impact: Strong diagnosis linkage reduces denial rate by approximately 30-40%
Submit pathology report with claim when possible, especially for initial submission to commercial payers
Impact: Reduces medical review requests and accelerates payment by 7-14 days on average
For Medicare patients, verify the procedure meets LCD/NCD requirements for muscle biopsy and ensure pre-authorization if required by MAC
Impact: Prevents denials averaging $207.66 per claim for failure to obtain prior authorization

Common denials

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 20200?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare payment rate for CPT code 20200 in 2025?

The 2025 Medicare national average payment for CPT 20200 is $207.66 in the non-facility setting and $93.80 in the facility setting. Actual reimbursement varies by geographic locality using the GPCI adjustment factors specific to your region.

What is the difference between CPT 20200 and 20205?

CPT 20200 is for superficial muscle biopsy, accessing muscle tissue close to the skin surface, while CPT 20205 covers deep muscle biopsy requiring more extensive dissection through multiple tissue planes. The depth of the target muscle and surgical approach determine the appropriate code selection.

How many RVUs is CPT code 20200 worth?

CPT 20200 has a total of 6.42 RVUs for 2025, consisting of 1.46 work RVUs, 4.58 non-facility practice expense RVUs (1.06 facility PE RVUs), and 0.38 malpractice RVUs based on the CMS Physician Fee Schedule.

Can CPT 20200 be billed bilaterally with modifier 50?

Yes, CPT 20200 can be billed with modifier 50 when superficial muscle biopsies are performed on both sides of the body during the same operative session. Medicare typically reimburses bilateral procedures at 150% of the unilateral rate, subject to MPPR reductions where applicable.

What diagnosis codes support medical necessity for CPT 20200?

Common supporting diagnoses include M60.9 (myositis unspecified), M62.81 (muscle weakness), G72.9 (myopathy unspecified), M33.20 (polymyositis), G71.0 (muscular dystrophy), and R79.89 (other abnormal blood chemistry such as elevated creatine kinase). Documentation must demonstrate why biopsy is necessary for diagnosis.

Do I need prior authorization for CPT 20200?

Prior authorization requirements vary by payer and state. Medicare typically does not require prior authorization for 20200, but many Medicare Advantage and commercial plans do. Always verify with the specific payer before scheduling, as retroactive denials for lack of authorization are typically not reversible.

Can CPT 20200 be billed with an E/M service on the same day?

Yes, but only if the E/M service represents a separately identifiable evaluation beyond the decision for surgery. Append modifier 25 to the E/M code and ensure documentation clearly shows the distinct nature of the evaluation, such as assessment of new symptoms or unrelated conditions.